logo BDSP

Base documentaire

  1. Fulltext. Screening for Helicobacter pylori and nonsteroidal anti-inflammatory drug use in Medicare patients hospitalized with Peptic ulcer disease.

    Article - En anglais



    Peptic ulcer disease has well-defined causes, with most cases related to Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use.


    To report performance rates on measures of care related to peptic ulcer disease in hospitalized Medicare patients and to identify improvement opportunities.


    Retrospective study of 2267 Medicare beneficiaries hospitalized with peptic ulcer disease.

    Data were obtained from 2 sources 

    Medical records (n=1580) from 80 hospitals-16 hospitals in each of 5 states (Alabama, Florida, Louisiana, Tennessee, and Texas) - and a national random sample (n=687).

    Three measures of care were evaluated 

    (1) rate of diagnostic screening or treatment for H pylori infection, (2) rate of screening for nonsteroidal anti-inflammatory drug use on admission to the hospital, and (3) rate of assessment of risk factors for recurrence.


    The rate of screening or treatment for H pylori infection was 52.9% to 59.8% among the 5 states and 55.6% in the national random sample.

    The rate of screening for nonsteroidal anti-inflammatory drug use was 64.6% to 75.4% among the states and 73.4% in the national random sample.

    The rate of assessment at discharge from the hospital for additional risks for ulcer recurrence was 66.1% to 73.6% among the states and 70.9% in the national random sample. (...)

    Mots-clés Pascal : Ulcère, Estomac, Dépistage, Helicobacter pylori, Spirillaceae, Spirillales, Bactérie, Complication, Chimiothérapie, Antiinflammatoire non stéroïde, Prévalence, Centre santé, Recommandation, Homme, Texas, Etats Unis, Amérique du Nord, Amérique, Appareil digestif pathologie, Estomac pathologie, Bactériose, Infection, Analgésique

    Mots-clés Pascal anglais : Ulcer, Stomach, Medical screening, Helicobacter pylori, Spirillaceae, Spirillales, Bacteria, Complication, Chemotherapy, Non steroidal antiinflammatory agent, Prevalence, Health center, Recommendation, Human, Texas, United States, North America, America, Digestive diseases, Gastric disease, Bacteriosis, Infection, Analgesic

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0108634

    Code Inist : 002B02H. Création : 16/11/1999.